Marimed (MRMD) Stock News

MariMed (CSE: MRMD / OTCQX: MRMD) issued a CEO statement on Dec. 18, 2025 responding to federal rescheduling of cannabis to Schedule III. The company called the move the "single greatest cannabis reform" and said it formally recognizes medical uses and lower abuse potential.

The statement says rescheduling will accelerate accredited medical research, expand consumer adoption as an alternative to opioids, and end the IRS Section 280E tax penalty for state-legal cannabis businesses—allowing compliant operators to be taxed like other consumer packaged goods sectors and, the company says, materially improve profitability and free cash flow.

MariMed (CSE: MRMD; OTCQX: MRMD) debuted an original song, Thrive: Anna, written by U.S. Army veteran and dispensary customer Ryan Taylor to celebrate his recovery and the welcoming environment at Thrive Dispensary in Anna, Illinois.

The company will play the song in-store across all 13 Thrive Dispensary locations in Massachusetts, Ohio, Delaware, Maryland, and Illinois, include a prerecorded introduction by a veteran team member, and make a donation to nonprofit FreedomSingsUSA in Taylor’s honor. Thrive: Anna is available for streaming on YouTube.

MariMed (CSE: MRMD / OTCQX: MRMD) launched a limited-edition winter flavor for its Betty’s Eddies cannabis fruit chews called Bundle Up Betty’s on Nov 18, 2025.

The seasonal chew combines real cranberry, orange, and warming spices and is infused with a relaxing blend of THC and CBD. Bundle Up Betty’s is available at select cannabis retailers and MariMed Thrive dispensaries in Massachusetts, Maryland, Illinois, and Delaware, and can be located via www.bettyseddies.com.

MariMed (CSE: MRMD, OTCQX: MRMD) reported third quarter results for the period ended September 30, 2025, with revenue of $40.8M and GAAP gross margin ~40%. The company reported a GAAP net loss of $2.9M for the quarter and a non-GAAP adjusted EBITDA of $5.1M.

Operationally, MariMed expanded branded distribution and management agreements: licensing Betty’s Eddies to Maine (July 14), a Managed Services Agreement and Pennsylvania licensing with TILT (July 31) with distribution anticipated in 2026, a New York licensing agreement (Oct 23) targeting 2026 distribution, and hemp‑derived THC manufacturing and distribution deals (Nov 3) with expected Rhode Island availability by early 2026. Management will host a conference call on Nov 6, 2025 at 8:00 AM ET.

MariMed (CSE: MRMD / OTCQX: MRMD) announced manufacturing and distribution agreements to launch hemp-derived THC versions of its beverage and edibles brands, including Vibations and Betty’s Eddies.

A hemp-derived THC Vibations drink mix is expected to be available in Rhode Island by early Q1 2026. The agreements establish an end-to-end hemp THC supply chain and create a new business unit, MMA Hemp Inc.

Partners named include DeHydr8 (manufacturing tech), Countermeasures (national sales/marketing), and Craft Collective Homegrown (Rhode Island distribution). According to BDSA, the hemp beverage market was $3.3B in 2024 and is projected to nearly double by 2029. Vibations and Betty’s Eddies are cited as top-selling brands in MariMed core markets.

MariMed (CSE: MRMD / OTCQX: MRMD) announced it has completed a strategic review and is exiting the Missouri market, effective immediately.

Since 2024 the company managed another licensed operator's Missouri facility under a Managed Services and Licensing Agreement while awaiting a license transfer; MariMed will no longer manage the facility or pursue the license transfer. The company continues to own or manage revenue-generating operations in six states, including 13 dispensaries and six cultivation and processing facilities across Delaware, Illinois, Maryland, Massachusetts, Ohio, and Pennsylvania. MariMed said the exit is expected to improve gross margin and adjusted EBITDA and let management redeploy resources to higher-return core markets. Management said it may consider future licensing with a vertical operator in Missouri if financially sensible.

MariMed (CSE: MRMD / OTCQX: MRMD) announced a licensing agreement with Farm 2 Hand to introduce MariMed’s top-selling edibles across New York State.

Farm 2 Hand will manufacture and distribute Betty’s Eddies™, Bubby’s Baked™, and InHouse™ gummies from a new kitchen that MariMed will design and equip at Farm 2 Hand’s Bronx facility. Terms were not disclosed. MariMed expects products to reach New York’s 500+ dispensaries in 2026, pending the kitchen build-out and regulatory approval. The company cited New York’s $6 billion total addressable market as a strategic expansion opportunity to drive wholesale revenue and brand awareness.

MariMed (OTCQX:MRMD) has launched the second annual Help on the Homefront campaign through its InHouse cannabis brand, offering veterans a chance to win financial support for housing costs. From October 1 to November 30, 2025, qualifying veterans in Maryland, Massachusetts, Delaware, and Illinois can enter to win $5,000 to help with housing expenses or home improvements.

The campaign, accessible through MariMed's Thrive dispensaries or online at inhousecannabis.com/veterans, will select one winner from each market before year-end. No purchase is necessary, and friends and family can submit entries on veterans' behalf. The initiative aims to address veteran housing challenges and homelessness while demonstrating MariMed's commitment to community support.

MariMed (OTCQX: MRMD), a prominent cannabis consumer packaged goods company and retailer, has scheduled its third quarter 2025 financial results announcement for November 5, 2025, after market close.

The company will host a conference call to discuss the results on November 6, 2025, at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available following the call.